BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31350329)

  • 1. A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in
    Komiya T; Blumenthal GM; DeChowdhury R; Fioravanti S; Ballas MS; Morris J; Hornyak TJ; Wank S; Hewitt SM; Morrow B; Memmott RM; Rajan A; Dennis PA
    Oncologist; 2019 Dec; 24(12):1510-e1265. PubMed ID: 31350329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies.
    Schmid GL; Kässner F; Uhlig HH; Körner A; Kratzsch J; Händel N; Zepp FP; Kowalzik F; Laner A; Starke S; Wilhelm FK; Schuster S; Viehweger A; Hirsch W; Kiess W; Garten A
    Pediatr Res; 2014 Apr; 75(4):527-34. PubMed ID: 24366516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin.
    Squarize CH; Castilho RM; Gutkind JS
    Cancer Res; 2008 Sep; 68(17):7066-72. PubMed ID: 18757421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
    Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
    Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
    Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
    Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
    Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
    J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin treatment for a child with germline PTEN mutation.
    Marsh DJ; Trahair TN; Martin JL; Chee WY; Walker J; Kirk EP; Baxter RC; Marshall GM
    Nat Clin Pract Oncol; 2008 Jun; 5(6):357-61. PubMed ID: 18431376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.
    Şahin GE; Hoşnut FÖ; Yeşil Ş; Lafcı NG; Gül AE; Şahin G
    Turk J Pediatr; 2022; 64(4):766-774. PubMed ID: 36082652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
    Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
    Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity.
    Cho MY; Kim HS; Eng C; Kim DS; Kang SJ; Eom M; Yi SY; Bronner MP
    Am J Surg Pathol; 2008 Aug; 32(8):1258-64. PubMed ID: 18594467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
    Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
    N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of TAS-117 in patients with advanced solid tumors harboring germline
    Rodón J; Funchain P; Laetsch TW; Arkenau HT; Hervieu A; Singer CF; Murciano-Goroff YR; Chawla SP; Anthony K; Yamamiya I; Liu M; Halim AB; Benhadji KA; Takahashi O; Delaloge S
    Future Oncol; 2022 Sep; 18(30):3377-3387. PubMed ID: 36039910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
    Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
    Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline PTEN mutations in Cowden syndrome-like families.
    Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
    J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
    Zabetian S; Mehregan D
    Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome.
    Chen HJ; Romigh T; Sesock K; Eng C
    Hum Mutat; 2017 Oct; 38(10):1372-1377. PubMed ID: 28677221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.